FDA Strategic Documents Outline Regulatory Science Priorities
This article was originally published in The Tan Sheet
Executive Summary
Improving regulatory tools and scientific know-how are among FDA's top priorities over the next five years, according to a draft strategic report
You may also be interested in...
FDA Budget Issues Creep Into Strategic Priorities
“Given the limited availability of investment capital for medical product development, early clarification of regulatory requirements is critical,” FDA says. Agency officials included stewardship, such as doing more with less funding, among the cross-cutting strategic priorities in its draft strategic priorities document for 2014-2018.
FDA Budget Issues Creep Into Strategic Priorities
“Given the limited availability of investment capital for medical product development, early clarification of regulatory requirements is critical,” FDA says. Agency officials included stewardship, such as doing more with less funding, among the cross-cutting strategic priorities in its draft strategic priorities document for 2014-2018.
FDA’s Regulatory Science Next Steps Include Food Safety Enforcement
FDA plans to invest in eight priority areas for regulatory science, including prevention-focused food safety enforcement and better tools for reviewing manufacturing systems, according to a strategic plan.